New York state and San Francisco declare monkeypox public health emergencies; COVID-19 boosters set for the summer have been scrapped in favor of fall boosters; HHS announces that insurers must cover birth control.
Monkeypox Declared Public Health Emergency in San Francisco, New York State
San Francisco and New York state have declared that monkeypox is a public health emergency, as its numbers continue to rise. These declarations come soon after the World Health Organization declared a global emergency. New York and California are home to more than 40% of the nation’s 4907 confirmed cases of monkeypox. Politicians in California said that this emergency declaration will make it easier to expand testing, mobilize resources, accelerate emergency planning, and expand access to vaccines. Currently, vaccines are believed to be effective before and after exposure to the disease.
Summer Boosters Shelved for People Under 50
The FDA is halting plans for a second COVID-19 booster that would be available this summer, instead deciding to focus on fall boosters that would provide immunization to the BA.5 variant. The decision to focus on this new generation of boosters was met with debate, as the FDA tried to balance keeping people in the summer safe while protecting people for next winter, when cases are expected to go up. The FDA believed that 2 boosters so close together may have prevented some from getting both boosters due to vaccine fatigue. Moderna and Pfizer-BioNTech are currently working with the FDA to have the fall boosters ready for October or November.
Biden Administration to Insurers: Cover Birth Control
The Biden administration warned businesses and health insurance providers in the United States that withholding coverage of contraceptives was against federal law. The HHS clarified by saying that the Affordable Care Act requires all insurance plans to provide free birth control and family-planning counseling to all insured individuals, including states that have banned or limited access to abortion. The warning comes as complaints of women not receiving coverage for their birth control have become more frequent across the country.
US ADHD Stimulant Shortage Highlights Growing Challenges in Adult Treatment
November 27th 2024While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear if it'll last; meanwhile, many generic forms of attention-deficit/hyperactivity disorder (ADHD) medication are still in short supply.
Read More
Facility Type Influences Antifibrotic Treatment Rates in Patients With IPF
November 27th 2024A study in Japan found that antifibrotic treatment rates for patients with idiopathic pulmonary fibrosis (IPF) varied by medical facility, with higher treatment rates observed in referral hospitals than in general hospitals or clinics.
Read More
Expert Insights on How Utilization Management Drives Physician Burnout
November 26th 2024On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The American Journal of Managed Care® to explore the link between utilization management and physician burnout.
Listen